ADVFN Logo ADVFN

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,598.76
-0.28%
US Tech 100
18,950.40
0.22%
Dow Jones
41,586.38
-0.78%
Brent Oil
69.91
1.26%
Bitcoin
81,309.20
3.61%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Altamira Therapeutics Ltd (CYTO)

  7. Altamira Therapeutics Ltd (CYTO) News

CYTO

Altamira Therapeutics (CYTO)

Altamira Therapeutics Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CYTO
DateTimeSourceHeadlineSymbolCompany
03/10/20254:30PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CYTOAltamira Therapeutics Ltd
12/20/20248:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CYTOAltamira Therapeutics Ltd
12/20/20248:00AMGlobeNewswire Inc.Altamira Therapeutics Announces Transition from NASDAQ to OTC MarketsNASDAQ:CYTOAltamira Therapeutics Ltd
10/04/20244:01PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CYTOAltamira Therapeutics Ltd
10/04/20244:01PMGlobeNewswire Inc.Altamira Therapeutics Provides Update on Nasdaq ListingNASDAQ:CYTOAltamira Therapeutics Ltd
09/27/20249:01AMGlobeNewswire Inc.Altamira Therapeutics Announces Extended ISO 13485 Quality Management System Certification for Bentrio Nasal SprayNASDAQ:CYTOAltamira Therapeutics Ltd
09/24/20248:15AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CYTOAltamira Therapeutics Ltd
09/24/20248:01AMGlobeNewswire Inc.Altamira Therapeutics Provides Business Update and First Half 2024 Financial ResultsNASDAQ:CYTOAltamira Therapeutics Ltd
09/20/20249:01AMGlobeNewswire Inc.Altamira Therapeutics to Host First Half 2024 Financial Results and Business Update Call on September 24, 2024NASDAQ:CYTOAltamira Therapeutics Ltd
09/19/20244:17PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CYTOAltamira Therapeutics Ltd
09/19/20244:01PMGlobeNewswire Inc.Altamira Therapeutics Announces Closing of up to $12.0 Million Public OfferingNASDAQ:CYTOAltamira Therapeutics Ltd
09/18/20244:19PMEdgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:CYTOAltamira Therapeutics Ltd
09/18/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CYTOAltamira Therapeutics Ltd
09/17/20245:00PMGlobeNewswire Inc.Altamira Therapeutics Announces Pricing of up to $12.0 Million Public OfferingNASDAQ:CYTOAltamira Therapeutics Ltd
09/16/20241:55PMEdgar (US Regulatory)Form F-1/A - Registration statement for certain foreign private issuers: [Amend]NASDAQ:CYTOAltamira Therapeutics Ltd
09/16/20249:29AMEdgar (US Regulatory)Form F-1/A - Registration statement for certain foreign private issuers: [Amend]NASDAQ:CYTOAltamira Therapeutics Ltd
09/16/20248:30AMGlobeNewswire Inc.Altamira Therapeutics Announces Expansion of Bentrio License and Distribution Agreement with Nuance Pharma in East and South East AsiaNASDAQ:CYTOAltamira Therapeutics Ltd
09/03/20249:01AMGlobeNewswire Inc.Altamira Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference September 9-11NASDAQ:CYTOAltamira Therapeutics Ltd
08/23/20249:01AMGlobeNewswire Inc.Altamira Therapeutics Announces Extension of Bentrio Distribution Agreement with Pharma Nordic to Include Sweden and DenmarkNASDAQ:CYTOAltamira Therapeutics Ltd
08/22/20244:53PMEdgar (US Regulatory)Form F-1 - Registration statement for certain foreign private issuersNASDAQ:CYTOAltamira Therapeutics Ltd
08/16/20249:01AMGlobeNewswire Inc.Altamira Therapeutics Announces Confirmed Suitability of Bentrio for Athletes as Comprehensive Testing Shows Absence of Prohibited SubstancesNASDAQ:CYTOAltamira Therapeutics Ltd
08/12/20249:02AMGlobeNewswire Inc.Altamira Therapeutics Announces Significant Enhancement of Immune Checkpoint Inhibition Therapy in Combination with Zbtb46 mRNA Delivered with SemaPhore Nanoparticles in Animal Tumor ModelsNASDAQ:CYTOAltamira Therapeutics Ltd
07/19/20249:01AMGlobeNewswire Inc.Altamira Therapeutics Announces Publication of Preclinical Data Showing Successful Treatment of Abdominal Aortic Aneurysm with SOD2 mRNA Delivered by SemaPhore NanoparticlesNASDAQ:CYTOAltamira Therapeutics Ltd
07/15/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CYTOAltamira Therapeutics Ltd
07/08/20245:17PMEdgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:CYTOAltamira Therapeutics Ltd
06/20/20249:01AMGlobeNewswire Inc.Altamira Therapeutics Highlights Newly Published Review Article Supporting Use of Betahistine in Vertigo ManagementNASDAQ:CYTOAltamira Therapeutics Ltd
05/28/202410:31AMGlobeNewswire Inc.Altamira Therapeutics Provides Business UpdateNASDAQ:CYTOAltamira Therapeutics Ltd
05/23/20248:47AMGlobeNewswire Inc.Altamira Therapeutics Announces Dissemination of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis Through Social Media Channels of Top Allergy JournalNASDAQ:CYTOAltamira Therapeutics Ltd
05/16/20244:15PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CYTOAltamira Therapeutics Ltd
05/01/20248:47AMGlobeNewswire Inc.Altamira Therapeutics Announces Filing of Provisional Patent Application for OligoPhore Nanoparticles with siRNA Targeting p65 Protein in Treatment of Cancer and InflammationNASDAQ:CYTOAltamira Therapeutics Ltd
 Showing the most relevant articles for your search:NASDAQ:CYTO

Your Recent History

NASDAQ
LICN
Lichen
NASDAQ
SRRK
Scholar Rock
NASDAQ
ISRG
Intuitive Surgical
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads